Stay updated on Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page
- Check4 days agoChange DetectedThe Record History now shows the latest version as Revision: v3.5.3, replacing the previous Revision: v3.5.2.SummaryDifference0.1%

- Check11 days agoChange DetectedUpdated the study’s overall status to **Completed** and revised its **Recruitment Status**. The prior **Active, not recruiting** state was removed.SummaryDifference0.4%

- Check18 days agoChange DetectedRevision: v3.5.2 has been added, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedAdded Revision: v3.5.0 to the history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedThe history now includes Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page shows a new Revision: v3.4.2 and removes the prior operating-status notice (Revision: v3.4.1).SummaryDifference0.5%

Stay in the know with updates to Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.